Extended-Release Calcifediol: A Data Journey From Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism November 2023
ASN Kidney Week 2023 Poster Presentation - Control of Secondary Hyperparathyroidism with Extended-release Calcifediol is Associated with Slower CKD Progression November 2023
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases May 2022
ASN Kidney Week 2021 Oral abstract presentation- Initial Evaluation of High-Dose Extended-Release Calcifediol (ERC) in Patients with Stage 5 CKD on Hemodialysis (HD) November 2021
Pituitary Society Presentation - Update on Somatrogon Development for the Treatment of Growth Hormone Deficiency in Pediatric and Adult Subjects October 2020
